Literature DB >> 8107262

Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus.

V A Mancuso1, T J Hope, L Zhu, D Derse, T Phillips, T G Parslow.   

Abstract

By systematically dissecting the Rev proteins of feline immunodeficiency virus (FIV) and equine infectious anemia virus (EIAV), we have identified within each a short peptide that is functionally interchangeable with the effector domains found in Rev-like proteins from other retroviruses. The active sequences from FIV and EIAV differ in several respects from other known effectors and may represent a distinct class of effector domain.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8107262      PMCID： PMC236666     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  22 in total

1.  Regulation by HIV Rev depends upon recognition of splice sites.

Authors:  D D Chang; P A Sharp
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

2.  Structural and functional characterization of the human immunodeficiency virus rev protein.

Authors:  A Perkins; A W Cochrane; S M Ruben; C A Rosen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

3.  rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.

Authors:  B K Felber; M Hadzopoulou-Cladaras; C Cladaras; T Copeland; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

4.  Trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I Rex transactivator.

Authors:  L Rimsky; M D Dodon; E P Dixon; W C Greene
Journal:  Nature       Date:  1989-10-05       Impact factor: 49.962

5.  Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function.

Authors:  M H Malim; S Böhnlein; J Hauber; B R Cullen
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

6.  Regulation of human immunodeficiency virus env expression by the rev gene product.

Authors:  M L Hammarskjöld; J Heimer; B Hammarskjöld; I Sangwan; L Albert; D Rekosh
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.

Authors:  R M Stephens; D Derse; N R Rice
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

8.  Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells.

Authors:  B Mermer; B K Felber; M Campbell; G N Pavlakis
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

9.  Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein.

Authors:  L Rimsky; J Hauber; M Dukovich; M H Malim; A Langlois; B R Cullen; W C Greene
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

10.  Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus.

Authors:  T R Phillips; C Lamont; D A Konings; B L Shacklett; C A Hamson; P A Luciw; J H Elder
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103
View more
  30 in total

1.  Identification of novel Saccharomyces cerevisiae proteins with nuclear export activity: cell cycle-regulated transcription factor ace2p shows cell cycle-independent nucleocytoplasmic shuttling.

Authors:  T H Jensen; M Neville; J C Rain; T McCarthy; P Legrain; M Rosbash
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence.

Authors:  M Dobbelstein; J Roth; W T Kimberly; A J Levine; T Shenk
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

3.  Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals.

Authors:  B E Meyer; J L Meinkoth; M H Malim
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein.

Authors:  M E Harris; R R Gontarek; D Derse; T J Hope
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

5.  Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay.

Authors:  H P Bogerd; R A Fridell; R E Benson; J Hua; B R Cullen
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

6.  The human T-cell leukemia virus type 1 posttranscriptional trans-activator Rex contains a nuclear export signal.

Authors:  D Palmeri; M H Malim
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  Biological characterization of Rev variation in equine infectious anemia virus.

Authors:  M Belshan; M E Harris; A E Shoemaker; T J Hope; S Carpenter
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

8.  Cellular protein modulates effects of human immunodeficiency virus type 1 Rev.

Authors:  Y Luo; H Yu; B M Peterlin
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation.

Authors:  K Engel; A Kotlyarov; M Gaestel
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

10.  Naturally arising point mutations in non-essential domains of equine infectious anemia virus Rev alter Rev-dependent nuclear-export activity.

Authors:  Wendy O Sparks; Karin S Dorman; Sijun Liu; Susan Carpenter
Journal:  J Gen Virol       Date:  2008-04       Impact factor: 3.891
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.